Formulation of Deformable Liponiosomal Hybrid of Repaglinide: In vitro Characterization and Evaluation of the Anti-Diabetic Effect
Ali F Abdelwahab,1 Alshimaa M Abdelmohymen,2 Nada M Mostafa,2 Galal Magdy,3 Eman A Mazyed4 1Department of Pharmacology, Faculty of Medicine, Cairo University, Cairo, Egypt; 2Department of Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt; 3Department of Pharmaceutical Analyti...
Main Authors: | Abdelwahab AF, Abdelmohymen AM, Mostafa NM, Magdy G, Mazyed EA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-12-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/formulation-of-deformable-liponiosomal-hybrid-of-repaglinide-in-vitro--peer-reviewed-fulltext-article-IJN |
Similar Items
-
Formulation and Optimization of Repaglinide Nanoparticles Using Microfluidics for Enhanced Bioavailability and Management of Diabetes
by: Mubashir Ahmad, et al.
Published: (2023-04-01) -
Development of Novel S-Protective Thiolated-Based Mucoadhesive Tablets for Repaglinide: Pharmacokinetic Study
by: Nabil A. Alhakamy, et al.
Published: (2022-08-01) -
Formulation of novel niosomal repaglinide chewable tablets using coprocessed excipients: in vitro characterization, optimization and enhanced hypoglycemic activity in rats
by: Shahinaze A. Fouad, et al.
Published: (2023-12-01) -
Assessment of Metabolic Interaction between Repaglinide and Quercetin via Mixed Inhibition in the Liver: In Vitro and In Vivo
by: Ji-Min Kim, et al.
Published: (2021-05-01) -
Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
by: Xie J, et al.
Published: (2019-04-01)